US Patent Issued to MEMORIAL SLOAN KETTERING CANCER CENTER on Aug. 26 for "Use of MVA or MVADELTAE3L as immunotherapeutic agents against solid tumors" (New York Inventors)

ALEXANDRIA, Va., Aug. 26 -- United States Patent no. 12,397,029, issued on Aug. 26, was assigned to MEMORIAL SLOAN KETTERING CANCER CENTER (New York).

"Use of MVA or MVADELTAE3L as immunotherapeutic agents against solid tumors" was invented by Liang Deng (New York), Jedd Wolchok (New York), Taha Merghoub (New York), Stewart Shuman (New York), Peihong Dai (New York) and Weiyi Wang (New York).

According to the abstract* released by the U.S. Patent & Trademark Office: "The present disclosure relates to modified vaccinia Ankara (MVA) virus or MVAtriangleE3L delivered intratumorally or systemically as an anticancer immunotherapeutic agent, alone, or in combination with one or more immune checkpoint blocking agents for the treatment of malignan...